Quality Systems – Page 24

Inventory control failure during transportation – how to prevent repeat excursions

“`html How to Mitigate Inventory Control Failures during Transportation in Pharma Operations Inventory control failures during transportation can disrupt pharmaceutical manufacturing processes and result in significant financial losses, regulatory scrutiny,…

IP risks during tech transfer during development – preventing repeat IP exposure

Identifying and Mitigating IP Risks During Technology Transfer in Pharmaceutical Development In the fast-paced environment of pharmaceutical development, technology transfer is critical but fraught with risks, particularly concerning intellectual property…

Supplier change unqualified during distribution qualification – how to prevent repeat excursions

Addressing Unqualified Supplier Changes During Distribution Qualification to Prevent Recurrences In the pharmaceutical manufacturing landscape, the integrity of the supply chain is paramount. A recent trend has revealed significant issues…

Data exclusivity lapse risk during lifecycle management – preventing repeat IP exposure

Mitigating Data Exclusivity Lapse Risks During Lifecycle Management As pharmaceutical companies maneuver through the complex landscape of lifecycle management, the risk of data exclusivity lapses can pose significant challenges. When…

Inventory control failure during distribution qualification – product quality risk assessment

Risk Assessment for Inventory Control Failures During Distribution Qualification Inventory control failures during the distribution qualification phase can lead to significant risks in product quality and regulatory compliance. Such situations…

Data exclusivity lapse risk during commercialization – risk mitigation and governance actions

Understanding and Mitigating Data Exclusivity Lapse Risks During Commercialization In today’s competitive pharmaceutical landscape, protecting your intellectual property through data exclusivity is crucial. However, lapses can occur during commercialization, leading…

Distribution temperature breach during storage – regulatory inspection outcome

Analyzing the Consequences of a Distribution Temperature Breach During Storage: An Investigative Approach In the pharmaceutical industry, maintaining stringent temperature controls during distribution is critical for product integrity and compliance.…

IP risks during tech transfer during lifecycle management – business and regulatory impact analysis

Understanding IP Risks During the Tech Transfer Process in Lifecycle Management In today’s pharmaceutical landscape, the transfer of technology during the product lifecycle presents notable risks, particularly regarding intellectual property…

Distribution temperature breach during inspection – regulatory inspection outcome

Analyzing a Distribution Temperature Breach During Inspection: Insights and Actions Experiencing a distribution temperature breach during an inspection can lead to serious regulatory repercussions and compromise product integrity. This article…

Freedom-to-operate gaps during due diligence – preventing repeat IP exposure

Identifying and Resolving Freedom-to-Operate Gaps During Due Diligence in Pharma The increasing complexity of pharmaceutical IP landscapes necessitates diligent oversight during due diligence processes. Low awareness or proactive measures can…

Transport qualification gaps during distribution qualification – how to prevent repeat excursions

Identifying and Addressing Transport Qualification Gaps During Distribution Qualification Transport qualification is a critical aspect of ensuring the integrity of pharmaceutical products during their distribution. Yet, lapses in this process…

IP risks during tech transfer during commercialization – preventing repeat IP exposure

Understanding and Mitigating IP Risks During Tech Transfer in Commercialization In the pharmaceutical sector, the transfer of technology during the commercialization phase is a critical but complex process that can…